levofloxacin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   137 Trials   137 Trials   5343 News 


«12...79808182838485868788899091»
  • ||||||||||  Trial completion date, Trial primary completion date:  BISER: Bacteriology and Inflammation in Bronchiectasis (clinicaltrials.gov) -  Aug 28, 2018   
    P=N/A,  N=80, Recruiting, 
    Trial completion date: Dec 2017 --> Dec 2020 | Trial primary completion date: Dec 2017 --> Dec 2020
  • ||||||||||  Orapenem (tebipenem pivoxil) / Meiji Seika, GSK
    Trial completion:  Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994 (clinicaltrials.gov) -  Aug 28, 2018   
    P1,  N=124, Completed, 
    Trial completion date: Dec 2017 --> Dec 2020 | Trial primary completion date: Dec 2017 --> Dec 2020 Recruiting --> Completed
  • ||||||||||  levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., azithromycin / Generic mfg.
    Trial completion date, Trial primary completion date:  Fluoroquinolone Associated Disability (clinicaltrials.gov) -  Aug 13, 2018   
    P=N/A,  N=100, Recruiting, 
    N=4000 --> 6800 | Trial completion date: Feb 2019 --> Jun 2022 | Trial primary completion date: Feb 2019 --> Dec 2021 | Initiation date: Dec 2015 --> Apr 2016 Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018
  • ||||||||||  Trial completion:  Tailored Therapy for Helicobacter Pylori Rescue Treatment (clinicaltrials.gov) -  Aug 7, 2018   
    P4,  N=200, Completed, 
    Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018 Recruiting --> Completed
  • ||||||||||  AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
    Trial completion date, Trial primary completion date:  Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) -  Jul 24, 2018   
    P=N/A,  N=20, Active, not recruiting, 
    Recruiting --> Completed Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019
  • ||||||||||  levofloxacin / Generic mfg., norfloxacin / Generic mfg., azithromycin / Generic mfg.
    Trial completion, Enrollment change, Adverse events, Serious adverse event:  A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events (clinicaltrials.gov) -  Jul 6, 2018   
    P=N/A,  N=117911, Completed, 
    Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019 Active, not recruiting --> Completed | N=15000 --> 117911
  • ||||||||||  levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., azithromycin / Generic mfg.
    Enrollment open:  Fluoroquinolone Associated Disability (clinicaltrials.gov) -  May 31, 2018   
    P=N/A,  N=100, Recruiting, 
    Active, not recruiting --> Completed | N=15000 --> 117911 Not yet recruiting --> Recruiting
  • ||||||||||  levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., azithromycin / Generic mfg.
    New trial:  Fluoroquinolone Associated Disability (clinicaltrials.gov) -  May 27, 2018   
    P=N/A,  N=100, Not yet recruiting, 
  • ||||||||||  prednisolone / Generic mfg., levofloxacin / Generic mfg.
    Trial completion date, Trial primary completion date:  Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia (clinicaltrials.gov) -  Apr 27, 2018   
    P4,  N=80, Recruiting, 
    Trial primary completion date: Mar 2018 --> Jun 2019 Trial completion date: Dec 2018 --> Dec 2020 | Trial primary completion date: Dec 2017 --> Dec 2020
  • ||||||||||  Trial completion:  Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment (clinicaltrials.gov) -  Apr 18, 2018   
    P4,  N=382, Completed, 
    Trial completion date: Dec 2018 --> Dec 2020 | Trial primary completion date: Dec 2017 --> Dec 2020 Active, not recruiting --> Completed
  • ||||||||||  Trial completion date, Trial primary completion date:  APPACIII: Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis (clinicaltrials.gov) -  Apr 9, 2018   
    P=N/A,  N=147, Enrolling by invitation, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Dec 2017 Trial completion date: Aug 2028 --> Aug 2029 | Trial primary completion date: Aug 2018 --> Mar 2019
  • ||||||||||  Dexilant (dexlansoprazole) / Takeda
    Trial completion:  Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori (clinicaltrials.gov) -  Apr 3, 2018   
    P4,  N=180, Completed, 
    Trial completion date: Aug 2028 --> Aug 2029 | Trial primary completion date: Aug 2018 --> Mar 2019 Recruiting --> Completed
  • ||||||||||  vancomycin / Generic mfg., levofloxacin / Generic mfg.
    Trial completion, Phase classification, Enrollment change, Trial completion date:  ANTHEM: Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria (clinicaltrials.gov) -  Mar 30, 2018   
    P,  N=20, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Phase classification: PN/A --> P | N=150 --> 20 | Trial completion date: Apr 2018 --> Jan 2018
  • ||||||||||  Enrollment change, Trial completion date:  Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment (clinicaltrials.gov) -  Mar 27, 2018   
    P4,  N=322, Recruiting, 
    Not yet recruiting --> Recruiting N=500 --> 322 | Trial completion date: Dec 2018 --> May 2018
  • ||||||||||  Orapenem (tebipenem pivoxil) / Meiji Seika, GSK
    Enrollment change, Trial completion date, Trial primary completion date:  Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994 (clinicaltrials.gov) -  Mar 20, 2018   
    P1,  N=152, Recruiting, 
    N=500 --> 322 | Trial completion date: Dec 2018 --> May 2018 N=56 --> 152 | Trial completion date: Jan 2018 --> Aug 2018 | Trial primary completion date: Jan 2018 --> Aug 2018
  • ||||||||||  Noxafil (posaconazole) / Merck (MSD)
    Trial completion date, Trial primary completion date:  Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients (clinicaltrials.gov) -  Mar 3, 2018   
    P=N/A,  N=1000, Recruiting, 
    N=56 --> 152 | Trial completion date: Jan 2018 --> Aug 2018 | Trial primary completion date: Jan 2018 --> Aug 2018 Trial completion date: Jan 2018 --> Mar 2018 | Trial primary completion date: Jan 2018 --> Mar 2018
  • ||||||||||  levofloxacin / Generic mfg.
    Enrollment closed, Trial completion date, Trial primary completion date, Combination therapy:  Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) -  Feb 27, 2018   
    P2,  N=111, Active, not recruiting, 
    Trial completion date: Jan 2018 --> Mar 2018 | Trial primary completion date: Jan 2018 --> Mar 2018 Completed --> Active, not recruiting | Trial primary completion date: Jul 2017 --> Mar 2019 | Trial completion date: Jul 2017 --> Mar 2019
  • ||||||||||  AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
    Trial primary completion date:  Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) -  Jan 29, 2018   
    P=N/A,  N=20, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Feb 2018 --> Feb 2018 Trial primary completion date: Dec 2017 --> Jun 2018
  • ||||||||||  levofloxacin / Generic mfg.
    Trial completion, Trial primary completion date:  PK of Levofloxacin in MDR-TB Patients (clinicaltrials.gov) -  Jan 25, 2018   
    P=N/A,  N=20, Completed, 
    Not yet recruiting --> Recruiting | Initiation date: Dec 2016 --> Aug 2017 Recruiting --> Completed | Trial primary completion date: May 2017 --> Oct 2017
  • ||||||||||  nitazoxanide / Generic mfg.
    Trial primary completion date:  A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) -  Jan 3, 2018   
    P3,  N=100, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2017 --> Dec 2022